Michael Milos Thornton

This profile gathers the share dealings of Michael Milos Thornton in ENDRA Life Sciences Inc., where the filings describe the role as senior executive. Over a trading history stretching from 12 May 2017 to 18 May 2023, the count stands at 15 filings.

The open-market side counts 6 purchases for €74k alongside 2 sales for €70k. Purchases outweigh sales by €4,001. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 4 share grants. In 2023 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €5,342. On 5 out of 6 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 22 May 2023: an open-market purchase of €23k, in ENDRA Life Sciences Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.